Trials in Cincinnati, Ohio
Here are the top 10 medical studies for depression in Cincinnati, Ohio
Popular Filters
Phase 3 Trials
Behavioural Intervention
Lumateperone for Pediatric Bipolar Depression
Recruiting1 awardPhase 3
Cincinnati, Ohio
"This trial is studying the effectiveness of a new treatment for children with bipolar disorder who are also experiencing major depressive episodes. The study is being conducted at multiple locations and will involve random assignment of participants to receive
Pharmacotherapy
Cariprazine for Bipolar Disorder in Youth
Recruiting1 awardPhase 3
West Chester, Ohio
This trial is testing the safety and effectiveness of Cariprazine for treating depressive episodes in children and teenagers with bipolar I disorder. The goal is to find out if Cariprazine can help young people with this condition. Cariprazine is an atypical antipsychotic recently approved for the treatment of depressive episodes in adults with bipolar I disorder.
Aticaprant + Antidepressant for Depression
Recruiting1 awardPhase 3
Cincinnati, Ohio
This trial aims to see if aticaprant is effective in preventing the return of depression symptoms when added to antidepressant therapy in individuals with major depressive disorder who have already responded well to aticaprant treatment
Lumateperone for Major Depressive Disorder
Recruiting1 awardPhase 3
Cincinnati, Ohio
This trial is testing lumateperone, a medication that may help people with depression who haven't improved with other treatments. The study includes patients diagnosed with Major Depressive Disorder who haven't responded well to their current antidepressants. Lumateperone works by balancing brain chemicals that affect mood, potentially improving depressive symptoms.
Trials With No Placebo
Behavioral Intervention
Internet Cognitive Behavioral Therapy for Depression
Recruiting1 award4 criteria
Indianapolis, Indiana
This trial aims to test an internet-based therapy program called Good Days Ahead (GDA) to help older intensive care unit (ICU) survivors who are experiencing depression and cognitive decline. The goal is
Behavioral Intervention
Coaching for Chronic Pain and Depression
Recruiting1 award2 criteria
Indianapolis, Indiana
This trial aims to test a coaching intervention for Black patients with chronic pain and depression. Patients will receive coaching sessions to help them understand and choose non-drug treatments for pain. The trial will enroll
Behavioural Intervention
BHV-7000 for Depression
Recruiting1 awardPhase 2
Dayton, Ohio
This trial is testing a new medication called BHV-7000 to see if it is safe and well-tolerated over several months in people with Major Depressive Disorder. The goal is to help those who suffer from severe depression by potentially offering a new treatment option.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.